Exhibit 99.2

WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended				Year Ended
	December 31,				December 31,
	2006		2005		2006		2005
Revenue	$	80,573	$	49,104	$	253,881	$	168,938
Costs and expenses:
Cost of operations		29,016		19,007		106,387		70,538
Sales and marketing		23,248		15,093		76,189		51,756
General and administrative		14,407		7,763		52,338		29,550
Depreciation and amortization		5,020		2,668		17,647		10,653
Interest income		962		1,780		5,099		1,790
Income before income tax provision		9,844		6,353		6,419		8,231
Income tax provision		965		222		1,873		486
Net income	$	8,879	$	6,131	$	4,546	$	7,745
Net income per common share:
Basic	$	0.16	$	0.11	$	0.08	$	0.15
Diluted	$	0.15	$	0.11	$	0.08	$	0.15
Weighted-average shares outstanding used in computing basic and diluted net income per common share:
Basic		56,411		56,054		56,145		50,132
Diluted		58,367		57,627		58,075		50,532

WEBMD HEALTH CORP.
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Year Ended
	December 31,						December 31,
	2006			2005			2006			2005 (c)
Revenue
Online Services:
Advertising and sponsorship	$	58,113		$	32,480		$	170,626		$	109,977
Licensing		17,306			11,016			55,621			34,113
Content syndication and other		703			1,513			3,518			8,210
Total Online Services		76,122			45,009			229,765			152,300
Publishing and Other Services		4,451			4,095			24,116			16,638
	$	80,573		$	49,104		$	253,881		$	168,938
Earnings (loss) before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”)(a)
Online Services	$	22,730		$	12,725		$	52,324		$	28,313
Publishing and Other Services		(410	)		(279	)		755			88
		22,320			12,446			53,079			28,401
Adjusted EBITDA per basic common share	$	0.40		$	0.22		$	0.95		$	0.57
Adjusted EBITDA per diluted common share	$	0.38		$	0.22		$	0.91		$	0.56
Interest, taxes, depreciation, amortization and other non-cash items (b)
Interest income		962			1,780			5,099			1,790
Depreciation and amortization		(5,020	)		(2,668	)		(17,647	)		(10,653	)
Non-cash advertising		(2,961	)		(3,871	)		(7,415	)		(8,992	)
Non-cash stock-based compensation		(5,457	)		(1,334	)		(26,697	)		(2,315	)
Income tax provision		(965	)		(222	)		(1,873	)		(486	)
Net income	$	8,879		$	6,131		$	4,546		$	7,745
Net income per common share:
Basic	$	0.16		$	0.11		$	0.08		$	0.15
Diluted	$	0.15		$	0.11		$	0.08		$	0.15
Weighted-average shares outstanding used in computing basic and diluted net income per common share:
Basic		56,411			56,054			56,145			50,132
Diluted		58,367			57,627			58,075			50,532

(a)	See Annex A — Explanation of Non-GAAP Financial Measures
(b)	Reconciliation of Adjusted EBITDA to net income
(c)	The year ended December 31, 2005 results include a $3,150 charge primarily related to severance expense incurred during the quarter ended June 30, 2005.

WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)

	December 31,		December 31,
	2006		2005
ASSETS
Current assets:
Cash and cash equivalents	$	44,660	$	75,704
Short-term investments		9,490		78,073
Accounts receivable, net		89,652		57,245
Current portion of prepaid advertising		2,656		7,424
Due from Emdeon		143,153		—
Other current assets		5,360		3,977
Total current assets		294,971		222,423
Property and equipment, net		44,709		21,014
Prepaid advertising		9,459		12,104
Goodwill		225,028		100,669
Intangible assets, net		45,268		20,503
Other assets		530		176
	$	619,965	$	376,889
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accrued expenses	$	32,846	$	30,400
Deferred revenue		77,731		36,495
Due to Emdeon		—		3,672
Total current liabilities		110,577		70,567
Other long-term liabilities		7,912		7,010
Stockholders’ equity		501,476		299,312
	$	619,965	$	376,889

WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Year Ended
	December 31,
	2006			2005
Cash flows from operating activities:
Net income	$	4,546		$	7,745
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		17,647			10,653
Non-cash advertising		7,414			8,992
Non-cash stock-based compensation		26,697			2,315
Reversal of income tax valuation allowance applied to goodwill		94			—
Changes in operating assets and liabilities:
Accounts receivable		(25,430	)		(13,974	)
Other assets		(800	)		(567	)
Accrued expenses and other long-term liabilities		6,699			10,721
Due (from) to Emdeon		(1,568	)		3,672
Deferred revenue		17,502			(952	)
Net cash provided by operating activities		52,801			28,605
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		304,184			87,450
Purchases of available-for-sale securities		(229,410	)		(165,178	)
Purchases of property and equipment		(28,452	)		(18,126	)
Cash paid in business combinations, net of cash acquired		(130,167	)		(50,752	)
Net cash used in investing activities		(83,845	)		(146,606	)
Cash flows from financing activities:
Proceeds from issuance of common stock		5,257			125,392
Net cash transfers with Emdeon		(5,257	)		64,857
Net cash provided by financing activities		—			190,249
Net (decrease) increase in cash and cash equivalents		(31,044	)		72,248
Cash and cash equivalents at beginning of period		75,704			3,456
Cash and cash equivalents at end of period	$	44,660		$	75,704